RATIONALE AND OBJECTIVES: Although multiple detector computed tomography (MDCT) and hyperpolarized gas magnetic resonance imaging (HP MRI) have demonstrated ability to detect structural and ventilation abnormalities in asthma, few studies have sought to exploit or cross-validate the regional information provided by these techniques. The purpose of this work is to assess regional disease in asthma by evaluating the association of sites of ventilation defect on HP MRI with other regional markers of airway disease, including air trapping on MDCT and inflammatory markers on bronchoscopy. MATERIALS AND METHODS: Both HP MRI using helium-3 and MDCT were acquired in the same patients. Supervised segmentation of the lung lobes on MRI and MDCT facilitated regional comparisons of ventilation abnormalities in the lung parenchyma. The percentage of spatial overlap was evaluated between regions of ventilation defect on HP MRI and hyperlucency on MDCT to determine associations between obstruction and likely regions of gas trapping. Similarly, lung lobes with high defect volume were compared to lobes with low defect volume for differences in inflammatory cell number and percentage using bronchoscopic assessment. RESULTS: There was significant overlap between sites of ventilation defect on HP MRI and hyperlucency on MDCT suggesting that sites of airway obstruction and air trapping are associated in asthma. The percent (r=0.68; P= .0039) and absolute (r=0.61; P= .0125) number of neutrophils on bronchoalveolar lavage for the sampled lung lobe also directly correlated with increased defect volume. CONCLUSIONS: These results show promise for using image guidance to assess specific regions of ventilation defect or air trapping in heterogeneous obstructive lung diseases such as asthma.
RATIONALE AND OBJECTIVES: Although multiple detector computed tomography (MDCT) and hyperpolarized gas magnetic resonance imaging (HP MRI) have demonstrated ability to detect structural and ventilation abnormalities in asthma, few studies have sought to exploit or cross-validate the regional information provided by these techniques. The purpose of this work is to assess regional disease in asthma by evaluating the association of sites of ventilation defect on HP MRI with other regional markers of airway disease, including air trapping on MDCT and inflammatory markers on bronchoscopy. MATERIALS AND METHODS: Both HP MRI using helium-3 and MDCT were acquired in the same patients. Supervised segmentation of the lung lobes on MRI and MDCT facilitated regional comparisons of ventilation abnormalities in the lung parenchyma. The percentage of spatial overlap was evaluated between regions of ventilation defect on HP MRI and hyperlucency on MDCT to determine associations between obstruction and likely regions of gas trapping. Similarly, lung lobes with high defect volume were compared to lobes with low defect volume for differences in inflammatory cell number and percentage using bronchoscopic assessment. RESULTS: There was significant overlap between sites of ventilation defect on HP MRI and hyperlucency on MDCT suggesting that sites of airway obstruction and air trapping are associated in asthma. The percent (r=0.68; P= .0039) and absolute (r=0.61; P= .0125) number of neutrophils on bronchoalveolar lavage for the sampled lung lobe also directly correlated with increased defect volume. CONCLUSIONS: These results show promise for using image guidance to assess specific regions of ventilation defect or air trapping in heterogeneous obstructive lung diseases such as asthma.
Authors: Saba Samee; Talissa Altes; Patrick Powers; Eduard E de Lange; Jack Knight-Scott; Gary Rakes; John P Mugler; Jonathan M Ciambotti; Bennet A Alford; James R Brookeman; Thomas A E Platts-Mills Journal: J Allergy Clin Immunol Date: 2003-06 Impact factor: 10.793
Authors: James H Holmes; Rafael L O'Halloran; Ethan K Brodsky; Youngkyoo Jung; Walter F Block; Sean B Fain Journal: Magn Reson Med Date: 2008-05 Impact factor: 4.668
Authors: Jim M Wild; Martyn N J Paley; Larry Kasuboski; Andrew Swift; Stan Fichele; Neil Woodhouse; Paul D Griffiths; Edwin J R van Beek Journal: Magn Reson Med Date: 2003-06 Impact factor: 4.668
Authors: Malcolm R Sears; Justina M Greene; Andrew R Willan; Elizabeth M Wiecek; D Robin Taylor; Erin M Flannery; Jan O Cowan; G Peter Herbison; Phil A Silva; Richie Poulton Journal: N Engl J Med Date: 2003-10-09 Impact factor: 91.245
Authors: Mario Castro; Sean B Fain; Eric A Hoffman; David S Gierada; Serpil C Erzurum; Sally Wenzel Journal: J Allergy Clin Immunol Date: 2011-06-02 Impact factor: 10.793
Authors: Mats W Johansson; Stanley J Kruger; Mark L Schiebler; Michael D Evans; Ronald L Sorkness; Loren C Denlinger; William W Busse; Nizar N Jarjour; Robert R Montgomery; Deane F Mosher; Sean B Fain Journal: Am J Respir Crit Care Med Date: 2013-07-15 Impact factor: 21.405
Authors: Wei Zha; Sean B Fain; Mark L Schiebler; Michael D Evans; Scott K Nagle; Fang Liu Journal: J Magn Reson Imaging Date: 2019-04-04 Impact factor: 4.813
Authors: Abhaya Trivedi; Chase Hall; Eric A Hoffman; Jason C Woods; David S Gierada; Mario Castro Journal: J Allergy Clin Immunol Date: 2017-01 Impact factor: 10.793
Authors: Rui Carlos Sá; Amran K Asadi; Rebecca J Theilmann; Susan R Hopkins; G Kim Prisk; Chantal Darquenne Journal: J Appl Physiol (1985) Date: 2014-02-06
Authors: Suphagaphan Ratanamaneechat; Donald R Neumann; Frank P Difilippo; Suzy A A Comhair; Kewal Asosingh; Sudakshina Ghosh; Deepa Grandon; Anam Khan; Mark A Aronica; Serpil C Erzurum Journal: Am J Respir Crit Care Med Date: 2014-03-15 Impact factor: 21.405
Authors: Robert V Cadman; Robert F Lemanske; Michael D Evans; Daniel J Jackson; James E Gern; Ronald L Sorkness; Sean B Fain Journal: J Allergy Clin Immunol Date: 2012-12-11 Impact factor: 10.793